Australian innovation gets a head start with Baxter Commercialisation
Baxter Innovation Hub has launched its new commercialisation service, Baxter Commercialisation, comprising an experienced team of industry specialists dedicated to assisting Australian inventors and entrepreneurs in expanding their business and selling their ideas to the world.
“The launch of Baxter Commercialisation has come at the right time for Australian innovators,” said the founder and director of the Baxter Innovation Hub, Chris Baxter. “With the Australian economy still riding high, our unique market size and sophistication, as well as our geographic advantages as we enter the Asian Century, Australians are in a good position to capitalise and commercialise their ideas.
“We have always been a highly creative country and we lead the pack when it comes to innovation - however, entrepreneurs are often hesitant in promoting their ideas, whether it’s facing international competition, finding the right contacts, securing angel investment and early-stage capital or effectively marketing their competitive advantages. What we do is help people step by step in seeing their investment funding needs met and their innovation commercialised.”
Baxter Commercialisation has a panel of over 15 commercialisation advisers specialising in key technologies and product segments, each bringing with them 15-20 years’ worth of network of industry contacts and investment funding partners.
“Our network of advisers are based in New Zealand, China, Hong Kong and the USA, so that we are able to connect our clients to investors, business partners and customers across the globe,” Baxter said.
The Baxter Innovation Hub started in 2007 with the establishment of Baxter IP Patent & Trademark Attorneys and has since grown into a hub of business activity that includes an industrial design studio, a social media marketing agency, an online video production company, an engineering consultancy specialising in medical devices and more; all of which work closely together to help innovators protect, license and promote their new ideas.
Vaxxas to advance its microarray patches for COVID vaccination
Vaxxas will receive AU$3.2m from BARDA to accelerate work advancing its high-density microarray...
Global competition targets 'undruggable' cancer protein
A new global competition offering over US$500,000 in prizes aims to spur drug discovery...
SMi Systems appoints Dr Ankur Mutreja as Senior Advisor
Mutreja was previously Head of Global South Partnerships at CEPI, where he was responsible for...